Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 2
2008 3
2010 4
2011 5
2012 3
2013 5
2014 5
2015 4
2016 9
2017 18
2018 18
2019 5
2020 17
2021 23
2022 25
2023 26
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.
Hu Y, Zhou Y, Zhang M, Ge W, Li Y, Yang L, Wei G, Han L, Wang H, Yu S, Chen Y, Wang Y, He X, Zhang X, Gao M, Yang J, Li X, Ren J, Huang H. Hu Y, et al. Among authors: zhou y. Clin Cancer Res. 2021 May 15;27(10):2764-2772. doi: 10.1158/1078-0432.CCR-20-3863. Epub 2021 Feb 24. Clin Cancer Res. 2021. PMID: 33627493 Clinical Trial.
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study.
Hu Y, Zhou Y, Zhang M, Zhao H, Wei G, Ge W, Cui Q, Mu Q, Chen G, Han L, Guo T, Cui J, Jiang X, Zheng X, Yu S, Li X, Zhang X, Chen M, Li X, Gao M, Wang K, Zu C, Zhang H, He X, Wang Y, Wang D, Ren J, Huang H. Hu Y, et al. Among authors: zhou y. Cell Res. 2022 Nov;32(11):995-1007. doi: 10.1038/s41422-022-00721-y. Epub 2022 Sep 23. Cell Res. 2022. PMID: 36151216 Free PMC article. Clinical Trial.
Main group metal polymerisation catalysts.
Fazekas E, Lowy PA, Abdul Rahman M, Lykkeberg A, Zhou Y, Chambenahalli R, Garden JA. Fazekas E, et al. Among authors: zhou y. Chem Soc Rev. 2022 Oct 31;51(21):8793-8814. doi: 10.1039/d2cs00048b. Chem Soc Rev. 2022. PMID: 36214205 Review.
A comprehensive overview of PPM1A: From structure to disease.
Li M, Xu X, Su Y, Shao X, Zhou Y, Yan J. Li M, et al. Among authors: zhou y. Exp Biol Med (Maywood). 2022 Mar;247(6):453-461. doi: 10.1177/15353702211061883. Epub 2021 Dec 3. Exp Biol Med (Maywood). 2022. PMID: 34861123 Free PMC article. Review.
The role of mediator complex subunit 19 in human diseases.
Zhang Y, Qin P, Tian L, Yan J, Zhou Y. Zhang Y, et al. Among authors: zhou y. Exp Biol Med (Maywood). 2021 Aug;246(15):1681-1687. doi: 10.1177/15353702211011701. Epub 2021 May 26. Exp Biol Med (Maywood). 2021. PMID: 34038190 Free PMC article. Review.
Correction: Main group metal polymerisation catalysts.
Fazekas E, Lowy PA, Abdul Rahman M, Lykkeberg A, Zhou Y, Chambenahalli R, Garden JA. Fazekas E, et al. Among authors: zhou y. Chem Soc Rev. 2023 Feb 6;52(3):1157. doi: 10.1039/d3cs90015k. Chem Soc Rev. 2023. PMID: 36688337
158 results